GenMark Diagnostics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GNMK and buy or sell other stocks, ETFs, and their options commission-free!About GNMK
GenMark Diagnostics, Inc. engages in the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its solutions include ePlex System and XT-8 System.
CEOTanya Monga
CEOTanya Monga
Employees—
Employees—
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded1993
Founded1993
Employees—
Employees—
GNMK Key Statistics
Market cap1.77B
Market cap1.77B
Price-Earnings ratio-84.89
Price-Earnings ratio-84.89
Dividend yield—
Dividend yield—
Average volume2.43M
Average volume2.43M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$24.25
52 Week high$24.25
52 Week low$8.47
52 Week low$8.47
Stock Snapshot
With a market cap of 1.77B, GenMark Diagnostics(GNMK) trades at $24.04. The stock has a price-to-earnings ratio of -84.89.
During the trading day, GenMark Diagnostics(GNMK) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for GenMark Diagnostics(GNMK) stock has reached 0, versus its average volume of 2.43M.
Over the past 52 weeks, GenMark Diagnostics(GNMK) stock has traded between a high of $24.25 and a low of $8.47.
Over the past 52 weeks, GenMark Diagnostics(GNMK) stock has traded between a high of $24.25 and a low of $8.47.
People also own
Based on the portfolios of people who own GNMK. This list is generated using Robinhood data, and it’s not a recommendation.